Boecking leads the Molecular Machines Group and is acting director of the EMBL Australia Node in Single Molecule Science. The group reconstitutes molecular machines — clathrin coat disassembly, HIV capsid assembly and uncoating, pore-forming toxins — and watches them work one molecule at a time by TIRF, interferometric scattering (mass photometry) and fluorescence fluctuation methods, resolving short-lived intermediates that ensemble kinetics averages into invisibility. He trained originally in surface chemistry and biosensors with Gooding, which gives the group unusual competence in engineering the surfaces these assays run on. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — the argument for single-molecule methods over ensemble ones is identical to the argument for pushing NV sensing below its pT/sqrt(Hz) ensemble regime: the interesting biology lives in heterogeneity and in transient states that averaging destroys. Strong methodological neighbour for a quantum-biosensing candidate.

Gooding is one of the world's most-cited biosensor scientists (inaugural editor-in-chief of ACS Sensors) and runs a group of over thirty researchers spanning surface chemistry, electrochemistry and nanomedicine. The sensing programme that matters here is the move from ensemble to digital, single-molecule-resolved detection: nanoparticle-tethered electrochemical sensors in which single binding events are counted rather than averaged, nanopore blockade sensors for protein biomarkers such as PSA, amplification-free nucleic-acid detection, and antifouling surface chemistries that make any of this work in real biological fluid. He has a strong commercialisation record (AgaMatrix glucose sensors). Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — his single-molecule-counting philosophy is the biosensing analogue of moving from a pT/sqrt(Hz) NV ensemble to single-spin detection: in both cases the sensitivity gain comes from resolving individual events rather than improving an averaged signal. He is also the obvious collaborator for anyone trying to functionalise a diamond or nanoparticle quantum sensor for a real analyte.

Graham's group develops SERS-based nanoplasmonic sensing platforms for biomedical applications. Research directions: (1) SERS nanogap substrates — engineering colloidal gold and silver nanostructure clusters with reproducible, high-enhancement nanogaps for single-molecule SERS detection; (2) In vivo SERS — intravenous SERS nanotags for tumor imaging and multiplexed biomarker detection in living organisms; (3) Microfluidic SERS — integrating SERS probes in microfluidic channels for continuous monitoring of circulating biomarkers; (4) Quantitative SERS — calibration strategies for absolute analyte quantification for clinical diagnostics. Extreme sensitivity (single-molecule) relevant to quantum-enhanced optical sensing.

Develops microfluidics and imaging-based spatial-omics technologies for high-resolution, high-throughput assays and modeling of complex biological systems, including bottom-up construction of synthetic cells.

Lee leads TheLeeLab at Cambridge Chemistry, focused on developing cutting-edge biophysical single-molecule fluorescence methods to answer fundamental biological questions. Two major thrusts: (1) 3D super-resolution microscopy instrument development — the lab pioneered single-molecule light field microscopy (SMLFM) using a microlens array in the back focal plane, achieving ~10× speed improvement over double-helix PSF for volumetric imaging; also develops vortex light field microscopy (VLFM) for simultaneous 25 nm spatial / 3 nm spectral precision; (2) Biological applications — studying T-cell receptor signalling at the nanoscale (distribution of TCRs, microvilli-mediated close contacts), histone assembly during DNA replication and repair in fission yeast, and PSD-95 nanoclusters in mouse brain using 3D SMLM. A job posting (PDRA) was active in 2025 for T-cell imaging work with super-resolution and Fourier light-field microscopy.

Micolich works on semiconductor nanowire and organic/polymer nanoelectronic devices, with two strands relevant here: the physics of low-dimensional transport and noise in nanowire transistors, and the use of those devices as transducers at the interface with biological systems, where a nanowire field-effect transistor acts as an extremely local potentiometer sensitive to charge and potential changes at the cell membrane. The group has a strong record in noise spectroscopy — using 1/f and random telegraph noise as a diagnostic rather than a nuisance. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — nanowire FET bioelectronic sensing is the principal electrical competitor to NV-based bio-magnetometry: both aim to read out cellular electrophysiology without patch-clamping, one via magnetic fields at pT/sqrt(Hz), the other via local potential. Borderline inclusion, kept because the bio-interface sensing thread is genuine.

Natrajan's group develops luminescent lanthanide complexes for chemical and biological sensing. Research directions: (1) Time-gated lanthanide luminescence sensing — long-lifetime Eu3+, Tb3+, and Yb3+ complexes with millisecond emission lifetimes for background-free sensing in cells and tissue; (2) Intracellular sensing — luminescent probes for sensing O2, pH, viscosity, and specific enzymes inside living cells with spatiotemporal resolution; (3) Chiral discrimination — circularly polarized luminescence (CPL) from Eu3+ complexes for enantioselective sensing; (4) Responsive probes — switchable lanthanide complexes as ratiometric sensors for biomedical imaging. The long-lifetime emission enables time-gating strategies analogous to quantum sensing protocols.

Nguyen's group at UCL (based at Royal Institution) focuses on magnetic and fluorescent nanoparticles for biomedical sensing and therapy. Research directions: (1) Magnetic nanoparticle synthesis — iron oxide (SPION) and other magnetic nanoparticles with controlled size, shape, and surface chemistry for MRI contrast and magnetic hyperthermia; (2) Biosensing platforms — functionalized nanoparticles as MRI-detectable sensors for specific biomolecular targets; magnetic particle imaging (MPI) for real-time tracking; (3) Plasmonic nanoparticles — gold nanoparticles for optical biosensing and photothermal therapy; (4) Fluorescent nanoparticles — QD- and dye-conjugated probes for live-cell imaging. Relevant to quantum sensing through magnetic nanoparticle platforms.

Reece runs UNSW's optical trapping and nanophotonics laboratory. The group combines optical tweezers with spectroscopy and microfluidics to characterise individual nanoparticles and cells: trapping and spectroscopically interrogating plasmonic core-satellite assemblies (with Gooding and Tilley), measuring single-cell mechanics, and building porous-silicon and photonic-crystal resonant structures for label-free biosensing where the analyte shifts a cavity resonance. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — optical trapping is the standard way to hold a nanoscale sensor — including a nanodiamond hosting an NV ensemble at pT/sqrt(Hz) — at a controlled position inside a cell or fluid, and levitated-nanodiamond spin-mechanics is an active field that this group's capabilities map onto almost exactly. Strong practical fit for a bio-oriented quantum sensing candidate.

Sierecki co-developed the cell-free single-molecule interaction platform with Gambin and runs a group applying it to protein interaction networks: mapping which proteins bind which, with what affinity and in what stoichiometry, at throughput high enough to screen rather than characterise one pair at a time. Recent applications include viral protein-host interactions and transcription factor complexes. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — the relevance to a quantum-sensing candidate is as a source of well-characterised, quantitatively-defined biological targets: a pT/sqrt(Hz)-class sensor is only useful in biology if someone can tell you exactly what molecular species is present and at what concentration, which is what this platform delivers. Borderline inclusion — no quantum or physics-instrumentation component — kept because single-molecule technique development is the core of the group.